Clinuvel Pharmaceuticals Limited Sponsored ADR (CUVL) Live Share Price, Invest From India

Clinuvel Pharmaceuticals Limited Sponsored ADR Stock Performance

as on October 21, 2026 at 6:19 am IST

Day's Low
$5.13
Day's Price Range
$5.19
$5.19
1.16%
Downside
52 Week's Low
52 Week's High
52-Week Price Range
$5.19
100.00%
Downside
-100.00%
Upside

Clinuvel Pharmaceuticals Limited Sponsored ADR share price movements today

Previous Close: $5.24
Open: $5.19
Volume: 30.3K
Market Cap: $266.1M
Dividend Yield: 0.69%
Day's Low - High: $5.13 - $5.19

Clinuvel Pharmaceuticals Limited Sponsored ADR Historical Returns

1 Month Return: -11.19 %
3 Month Return: -29.19 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Clinuvel Pharmaceuticals Limited Sponsored ADR Stock Fundamentals & Key Indicators

Check Clinuvel Pharmaceuticals Limited Sponsored ADR market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$266.1M

EPS (TTM)

Dividend Yield

0.69%

PE Ratio (TTM)

11.63

PEG Ratio

0.00

Return On Equity TTM

13.21%

Clinuvel Pharmaceuticals Limited Sponsored ADR vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Clinuvel Pharmaceuticals Limited Sponsored ADR with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Clinuvel Pharmaceuticals Limited Sponsored ADR	NA	$266.1M	NA	11.63	36.07%	0.69%
Moderna	Neutral	$87.0B	-31.87%	-27.32	-12.57%	0.00%
Vertex Pharmaceuticals	StrongBuy	$126.7B	170.61%	28.85	86.04%	0.00%
Regeneron	Buy	$81.4B	38.98%	18.88	84.86%	0.47%

Indian Investors' Interest in Clinuvel Pharmaceuticals Limited Sponsored ADR Stock

Search interest for Clinuvel Pharmaceuticals Limited Sponsored ADR Stock has decreased by -87% in the last 30 days, reflecting a downward trend in search activity.

Time period: September 21, 2026 to October 21, 2026

Change:-87% versus previous 30 day period

Clinuvel Pharmaceuticals Limited Sponsored ADR Annual Profit & Loss

All numbers in Millions USD

	Jun 2022	Jun 2023	Jun 2024	Jun 2025	Jun 2026
Total Revenue	46	52	58	95	94
Gross Profit	38	46	51	79	78
Operating Income	35	44	48	45	39
EBITDA	-	49	56	57	40
Interest Expense	2	3	4	4	-
Depreciation	0	0	1	1	0
Income Before Tax	34	45	50	51	47
Income Tax Expense	-	-	-	-	-
Net Income	14	20	23	36	33
Net Profit Margin	31.77%	39.08%	40.41%	38.07%	36.07%

Clinuvel Pharmaceuticals Limited Sponsored ADR Annual Cash Flow

All numbers in Millions USD

	Jun 2023	Jun 2024	Jun 2025	Jun 2026
Net Income	30	35	36	33
Operating Cash Flow	-	-	-	-
Investing Cash Flow	-	-	-	-
Financing Cash Flow	-2	-3	-2	-2
Change in Cash	33	4	-9	-4

Insights on Clinuvel Pharmaceuticals Limited Sponsored ADR

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NEGATIVE IMPACT
Price Dip
In the last 7 days, CUVL stock has moved down by -3.7%

About Clinuvel Pharmaceuticals Limited Sponsored ADR

Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally. Its lead drug candidate is SCENESSE, a systemic photoprotective drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria (EPP). The company's pipeline products include CUV9900, an alpha-melanocyte stimulating hormone analogue; and PRÉNUMBRA, a liquid injectable formulation of afamelanotide. It is also developing NEURACTHEL (ACTH), an adrenocorticotropic hormone for targeting neurological, endocrinological, and degenerative disorders; and pharmaceutical formulations melanocortin technology for the treatment of a range of disorders. In addition, the company provides photocosmetic products for individuals and populations at risk of exposure to ultraviolet and high energy visible light, and in need of assistance in DNA repair and melanogenesis of the skin. The company was incorporated in 1999 and is headquartered in Melbourne, Australia.

Organisation	Clinuvel Pharmaceuticals Limited Sponsored ADR
Headquarters	535 Bourke Street, Melbourne, VIC, 3000, AU
Industry	Medical - Pharmaceuticals
CEO	Philippe Jacques Wolgen

Key Management of Clinuvel Pharmaceuticals Limited Sponsored ADR

Name	Title
Mr. Lachlan Hay	Chief Operations Officer
Dr. Dennis J. Wright BPharm, M.Sc., Ph.D.	Chief Scientific Officer
Mr. Malcolm Bull	Head of Australian Operations & Investor Relations
Dr. Emilie Rodenburger	Director of Global Clinical Affairs
Dr. Philippe Jacques Wolgen M.B.A., M.D.	CEO, MD & Director
Mr. Peter Vaughan	Chief Financial Officer
Dr. Azza Hamila	Head of Quality Assurance & Drug Safety
Ms. Claire Newstead-Sinclair C.A.	Company Secretary
Dr. Linda Teng	Director of North American Operations

FAQs

What is Clinuvel Pharmaceuticals Limited Sponsored ADR share price today?

Clinuvel Pharmaceuticals Limited Sponsored ADR share price today is $5.19 as on October 21, 2026 at 12:49 am IST at the close of the market. Clinuvel Pharmaceuticals Limited Sponsored ADR share today touched a day high of $5.19 and a low of $5.13.

What is the 52 week high and 52 week low for Clinuvel Pharmaceuticals Limited Sponsored ADR share?

Clinuvel Pharmaceuticals Limited Sponsored ADR share touched a 52 week high of $0.00 on January 1, 1970 and a 52 week low of $0.00 on January 1, 1970. Clinuvel Pharmaceuticals Limited Sponsored ADR stock price today i.e. October 21, 2026 at 12:49 am IST is closed at $5.19,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Clinuvel Pharmaceuticals Limited Sponsored ADR's market capitalisation today?

Clinuvel Pharmaceuticals Limited Sponsored ADR market capitalisation is $0.00T as on October 21, 2026 at 12:49 am IST.

How to invest in Clinuvel Pharmaceuticals Limited Sponsored ADR Stock (CUVL) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Clinuvel Pharmaceuticals Limited Sponsored ADR on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Clinuvel Pharmaceuticals Limited Sponsored ADR Stock (CUVL) from India?

Indian investors can start investing in Clinuvel Pharmaceuticals Limited Sponsored ADR (CUVL) shares with as little as ₹94.93000030517578 or $1 (as of October 21, 2026 at 5:45 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹949.30 in Clinuvel Pharmaceuticals Limited Sponsored ADR stock (as per the Rupee-Dollar exchange rate as on October 21, 2026 at 5:45 am IST). Based on Clinuvel Pharmaceuticals Limited Sponsored ADR share’s latest price of $5.19 as on October 21, 2026 at 12:49 am IST, you will get 1.9268 shares of Clinuvel Pharmaceuticals Limited Sponsored ADR. Learn more about fractional shares .